Lung adenocarcinoma patient refractory to gefitinib and responsive to crizotinib, with concurrent rare mutation of the epidermal growth factor receptor (L861Q) and increased ALK/MET/ROS1 gene copy Number

Sara Pilotto, Emilio Bria, Umberto Peretti, Francesco Massari, Marina Garassino, Giuseppe Pelosi, Giampaolo Tortora

Research output: Contribution to journalArticle

Original languageEnglish
JournalJournal of Thoracic Oncology
Volume8
Issue number12
DOIs
Publication statusPublished - 2013

ASJC Scopus subject areas

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Medicine(all)

Cite this